BOXED WARNING Concomitant use with opioids may cause profound sedation, respiratory depression, coma, death; risk of abuse, misuse, and addiction; physical dependence and life-threatening withdrawal — taper gradually to discontinue.
FDA dosing
Population
Start
Target
Max
Anxiety
Adults
2–3 mg/day BID–TID
2–6 mg/day divided (range 1–10 mg/day)
10 mg/day
Insomnia due to anxiety or transient stress
Adults
2–4 mg QHS
Anxiety
Elderly / debilitated
1–2 mg/day divided
Renal Undefined
Hepatic Undefined
Instructions
Individualize dose; take the largest dose at bedtime
Increase the evening dose before daytime doses
Taper gradually to discontinue; if withdrawal occurs, pause taper or return to prior dose, then decrease more slowly
Contraindications
Acute narrow-angle glaucoma
Cautions
Respiratory depression/sedation with opioids or other CNS depressants
Abuse, misuse, and addiction
Physical dependence and life-threatening withdrawal (taper to stop)